| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Novel N-(phosphonomethyl) glycine derivatives: Design, characterization and biological activity.
|
Eur J Med Chem
|
2007
|
0.88
|
|
2
|
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity.
|
Cancer Chemother Pharmacol
|
2010
|
0.84
|
|
3
|
Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells.
|
Cancer Lett
|
2002
|
0.81
|
|
4
|
Induction of apoptosis by erucylphospho-N,N,N-trimethylammonium is associated with changes in signal molecule expressionand location.
|
Ann N Y Acad Sci
|
2003
|
0.80
|
|
5
|
An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene.
|
Hematology
|
2010
|
0.80
|
|
6
|
The expression level of the tumor suppressor retinoblastoma protein (Rb) influences the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium (ErPC3).
|
Cancer Biol Ther
|
2007
|
0.77
|
|
7
|
Erucylphospho-N,N,N-trimethylpropylammonium shows substantial cytotoxicity in multiple myeloma cells.
|
Ann N Y Acad Sci
|
2009
|
0.77
|
|
8
|
Antineoplastic and anticlastogenic properties of curcumin.
|
Ann N Y Acad Sci
|
2007
|
0.77
|
|
9
|
Interleukin-6, osteopontin and Raf/MEK/ERK signaling modulate the sensitivity of human myeloma cells to alkylphosphocholines.
|
Leuk Res
|
2012
|
0.76
|
|
10
|
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
|
J Cancer Res Clin Oncol
|
2012
|
0.76
|
|
11
|
In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
|
Ann N Y Acad Sci
|
2009
|
0.75
|
|
12
|
Effects of the plant alkaloid thaliblastine on non-cross-resistant and sensitive human leukemia cells in relation with reversal of acquired anthracycline resistance.
|
Fitoterapia
|
2004
|
0.75
|
|
13
|
A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target.
|
Hematology
|
2012
|
0.75
|